Stanford researchers have discovered a breakthrough technology that shrinks and removes blood clots to treat strokes, heart attacks, and other clot-related diseases.

Access to better care, rapid intervention, and standardized procedures with predictable outcomes is critical for treating ...

Time-sensitive treatments like clot-dissolving medications and mechanical clot removal procedures can restore blood flow to affected brain areas and minimize permanent damage.

Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of enrollment in STORM-PE clinical trial. The pivotal, ...

Penumbra's aspiration-based mechanical thrombectomy devices are building one of the most defensible competitive moats in ...

Nearly 80% of all stroke survivors experience walking issues and turn to ankle braces for increased support, but ankle braces are still very limited and many stroke survivors report no improvements ...

CAMPBELL, Calif., July 16, 2025--Imperative Care, Inc. announces a late-breaking abstract with data evaluating aspiration with the Zoom System in stroke patients with M2 occlusions.

Surmodics said that to its knowledge, the threat actor had not released any of its data or used it for any fraudulent purposes.

By densifying the clot’s fibrin network and releasing red blood cells, it offers a new strategy to improve success rates in treatments of blood-clot blockages, such as stroke.